Zemedy Application for Irritable Bowel Syndrome

N/A

Waitlist Available

Led By Linda Nguyen, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Meet Rome IV criteria for IBS for at least 6 months. No restrictions on type of IBS.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and at week 24.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether the Zemedy app can help people with IBS by providing a CBT program digitally.

Who is the study for?

This trial is for adults over 18 with Irritable Bowel Syndrome (IBS) who have had symptoms for at least 6 months. Participants must speak English, have been on a stable IBS treatment for 30 days, and own a smartphone to use the Zemedy app.

What is being tested?

The study tests the effectiveness of Zemedy, a mobile app delivering cognitive behavioral therapy (CBT) programs to help manage IBS symptoms.

What are the potential side effects?

Since Zemedy is an application providing CBT and not a medication, it may not have typical drug side effects. Users might experience discomfort if new to CBT or stress from regular engagement with the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with IBS for at least 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and at week 24.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and at week 24.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at week 24. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

IBS-SSS at 8 Weeks

Secondary study objectives

IBS-SSS at 24 Weeks

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental (TAU plus CBT)Experimental Treatment1 Intervention

Subjects who are in the Experimental Group will receive 8 weeks of CBT from the Zemedy mobile application in addition to their treatment as usual (TAU).

Group II: Control Group (TAU only)Active Control1 Intervention

Treatment as Usual (TAU) for IBS patients are tailored to each individual's needs and may involve treatment such as: dietary modification, exercise, medication, and anti-diarrheal therapy.

0 / 1Eligibility criteria met